Articles: disease.
-
Historical Article
Evolution of paediatric oncology over the years: overview with a focus on sub-Saharan Africa and examples from the Kenyan experience.
In this paper on "The Evolution of Paediatric Oncology Over the Years", a historical perspective is outlined regarding the subspecialty of paediatric oncology on a global basis. The evolution of paediatric oncology units and their role in the progress of cancer management in children is highlighted. ⋯ The development of a paediatric oncology unit at the Kenyatta National Hospital in Nairobi, Kenya has been focused on, pointing out challenges, constraints and success that are associated in the initiation and nurturing of such units in developing countries. Lastly, Burkitt's lymphoma is singled out for discussion to illustrate problems that are abound in cancer management in children in sub-Saharan Africa.
-
Ninety neonates were ventilated over a period of 33 months of whom 50 (55.5%) survived. Fifty seven babies received IPPV while 33 CPAP. IPPV mode was being used more frequently recently and survival rates have steadily improved over past 3 years. ⋯ Two babies developed BPD and one ROP. Neonatal ventilation should be ventured in centres where basic facilities for level II care already exist. It may not be cost effective to ventilate extremely low birth weight neonates.
-
We report on the determinants and consequences of induced abortion among 803 women admitted to hospital with abortion complications in Rio de Janeiro, Brazil, in 1991. 458 (57%) women reported using misoprostol to induce abortion, 74% in the first 4 months of pregnancy. Doses of 200-16,800 micrograms were reported, with a median of 800 micrograms. 65% of the women took the drug orally, 29% used a combination of oral and vaginal routes, and 6% administered it intravaginally. Vaginal bleeding and uterine cramps were the commonest reasons for seeking hospital care. ⋯ A significantly smaller proportion of women taking misoprostol than of those who induced abortion by catheter insertion presented signs of infection or physical injuries or required blood transfusion (< 0.0005). Among 803 women interviewed at delivery as controls, 6% had taken misoprostol but abortion had not ensued. Misoprostol has an important role as an abortifacient among the women studied.